Please visit the main LLS News page for all blood cancer updates including patient care, advocacy and fundraising.
BREAKING NEWS:
IMPACT accepting Letters of Intent NOW
SCOR accepting Letters of Intent NOW
-->
For the latest from LLS Research please follow us on Twitter:
Latest Tweets by LLSResearch
Some of our latest news:
FDA Approves New Formulation of Important Childhood Leukemia Drug
The U.S. Food and Drug Administration yesterday approved nelarabine injection, a critical treatment for T-cell acute lymphoblastic leukemia (T-ALL), an aggressive blood cancer that is most common in children.